The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease

Prognostic relevance of coronary collateral function: confounded or causal relationship?

(2013) Christian Seiler et al.   HEART

Determinants of Prognostically Relevant Intracoronary Electrocardiogram ST-Segment Shift During Coronary Balloon Occlusion

(2012) Stefano Fausto de Marchi et al.   AMERICAN JOURNAL OF CARDIOLOGY

Determinants of Preformed Collateral Vessels in the Human Heart without Coronary Artery Disease

(2011) Stefano F. de Marchi et al.   CARDIOLOGY

Arterial Pulse Wave Dynamics After Percutaneous Aortic Valve Replacement

(2011) Justin E. Davies et al.   CIRCULATION

Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis

(2011) Stephan H. Schirmer et al.   EUROPEAN HEART JOURNAL

Physical Coronary Arteriogenesis: A Human “Model” of Collateral Growth Promotion

(2011) Rolf Vogel et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial)

(2009) E. E. Buschmann et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Coronary collateral growth by external counterpulsation: a randomised controlled trial

(2009) S. Gloekler et al.   HEART

Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction

(2008) G Heusch   BRITISH JOURNAL OF PHARMACOLOGY

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET